8 research outputs found
5to. Congreso Internacional de Ciencia, Tecnología e Innovación para la Sociedad. Memoria académica
El V Congreso Internacional de Ciencia, Tecnología e Innovación para la Sociedad, CITIS 2019, realizado del 6 al 8 de febrero de 2019 y organizado por la Universidad Politécnica Salesiana, ofreció a la comunidad académica nacional e internacional una plataforma de comunicación unificada, dirigida a cubrir los problemas teóricos y prácticos de mayor impacto en la sociedad moderna desde la ingeniería.
En esta edición, dedicada a los 25 años de vida de la UPS, los ejes temáticos estuvieron relacionados con la aplicación de la ciencia, el desarrollo tecnológico y la innovación en cinco pilares fundamentales de nuestra sociedad: la industria, la movilidad, la sostenibilidad ambiental, la información y las telecomunicaciones.
El comité científico estuvo conformado formado por 48 investigadores procedentes de diez países: España, Reino Unido, Italia, Bélgica, México, Venezuela, Colombia, Brasil, Estados Unidos y Ecuador.
Fueron recibidas un centenar de contribuciones, de las cuales 39 fueron aprobadas en forma de ponencias y 15 en formato poster. Estas contribuciones fueron presentadas de forma oral ante toda la comunidad académica que se dio cita en el Congreso, quienes desde el aula magna, el auditorio y la sala de usos múltiples de la Universidad Politécnica Salesiana, cumplieron respetuosamente la responsabilidad de representar a toda la sociedad en la revisión, aceptación y validación del conocimiento nuevo que fue presentado en cada exposición por los investigadores.
Paralelo a las sesiones técnicas, el Congreso contó con espacios de presentación de posters científicos y cinco workshops en temáticas de vanguardia que cautivaron la atención de nuestros docentes y estudiantes. También en el marco del evento se impartieron un total de ocho conferencias magistrales en temas tan actuales como la gestión del conocimiento en la universidad-ecosistema, los retos y oportunidades de la industria 4.0, los avances de la investigación básica y aplicada en mecatrónica para el estudio de robots de nueva generación, la optimización en ingeniería con técnicas multi-objetivo, el desarrollo de las redes avanzadas en Latinoamérica y los mundos, la contaminación del aire debido al tránsito vehicular, el radón y los riesgos que representa este gas radiactivo para la salud humana, entre otros
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
Background: Estimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand this unprecedented event within the context of long-term population health trends. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides new demographic estimates for 204 countries and territories and 811 additional subnational locations from 1950 to 2021, with a particular emphasis on changes in mortality and life expectancy that occurred during the 2020–21 COVID-19 pandemic period. Methods: 22 223 data sources from vital registration, sample registration, surveys, censuses, and other sources were used to estimate mortality, with a subset of these sources used exclusively to estimate excess mortality due to the COVID-19 pandemic. 2026 data sources were used for population estimation. Additional sources were used to estimate migration; the effects of the HIV epidemic; and demographic discontinuities due to conflicts, famines, natural disasters, and pandemics, which are used as inputs for estimating mortality and population. Spatiotemporal Gaussian process regression (ST-GPR) was used to generate under-5 mortality rates, which synthesised 30 763 location-years of vital registration and sample registration data, 1365 surveys and censuses, and 80 other sources. ST-GPR was also used to estimate adult mortality (between ages 15 and 59 years) based on information from 31 642 location-years of vital registration and sample registration data, 355 surveys and censuses, and 24 other sources. Estimates of child and adult mortality rates were then used to generate life tables with a relational model life table system. For countries with large HIV epidemics, life tables were adjusted using independent estimates of HIV-specific mortality generated via an epidemiological analysis of HIV prevalence surveys, antenatal clinic serosurveillance, and other data sources. Excess mortality due to the COVID-19 pandemic in 2020 and 2021 was determined by subtracting observed all-cause mortality (adjusted for late registration and mortality anomalies) from the mortality expected in the absence of the pandemic. Expected mortality was calculated based on historical trends using an ensemble of models. In location-years where all-cause mortality data were unavailable, we estimated excess mortality rates using a regression model with covariates pertaining to the pandemic. Population size was computed using a Bayesian hierarchical cohort component model. Life expectancy was calculated using age-specific mortality rates and standard demographic methods. Uncertainty intervals (UIs) were calculated for every metric using the 25th and 975th ordered values from a 1000-draw posterior distribution. Findings: Global all-cause mortality followed two distinct patterns over the study period: age-standardised mortality rates declined between 1950 and 2019 (a 62·8% [95% UI 60·5–65·1] decline), and increased during the COVID-19 pandemic period (2020–21; 5·1% [0·9–9·6] increase). In contrast with the overall reverse in mortality trends during the pandemic period, child mortality continued to decline, with 4·66 million (3·98–5·50) global deaths in children younger than 5 years in 2021 compared with 5·21 million (4·50–6·01) in 2019. An estimated 131 million (126–137) people died globally from all causes in 2020 and 2021 combined, of which 15·9 million (14·7–17·2) were due to the COVID-19 pandemic (measured by excess mortality, which includes deaths directly due to SARS-CoV-2 infection and those indirectly due to other social, economic, or behavioural changes associated with the pandemic). Excess mortality rates exceeded 150 deaths per 100 000 population during at least one year of the pandemic in 80 countries and territories, whereas 20 nations had a negative excess mortality rate in 2020 or 2021, indicating that all-cause mortality in these countries was lower during the pandemic than expected based on historical trends. Between 1950 and 2021, global life expectancy at birth increased by 22·7 years (20·8–24·8), from 49·0 years (46·7–51·3) to 71·7 years (70·9–72·5). Global life expectancy at birth declined by 1·6 years (1·0–2·2) between 2019 and 2021, reversing historical trends. An increase in life expectancy was only observed in 32 (15·7%) of 204 countries and territories between 2019 and 2021. The global population reached 7·89 billion (7·67–8·13) people in 2021, by which time 56 of 204 countries and territories had peaked and subsequently populations have declined. The largest proportion of population growth between 2020 and 2021 was in sub-Saharan Africa (39·5% [28·4–52·7]) and south Asia (26·3% [9·0–44·7]). From 2000 to 2021, the ratio of the population aged 65 years and older to the population aged younger than 15 years increased in 188 (92·2%) of 204 nations. Interpretation: Global adult mortality rates markedly increased during the COVID-19 pandemic in 2020 and 2021, reversing past decreasing trends, while child mortality rates continued to decline, albeit more slowly than in earlier years. Although COVID-19 had a substantial impact on many demographic indicators during the first 2 years of the pandemic, overall global health progress over the 72 years evaluated has been profound, with considerable improvements in mortality and life expectancy. Additionally, we observed a deceleration of global population growth since 2017, despite steady or increasing growth in lower-income countries, combined with a continued global shift of population age structures towards older ages. These demographic changes will likely present future challenges to health systems, economies, and societies. The comprehensive demographic estimates reported here will enable researchers, policy makers, health practitioners, and other key stakeholders to better understand and address the profound changes that have occurred in the global health landscape following the first 2 years of the COVID-19 pandemic, and longer-term trends beyond the pandemic
Diseñar un manual de procedimientos en tomografía computarizada en exámenes contrastados, para el servicio de imagenología del Hospital José Carrasco Arteaga, Cuenca. 2014-2015
En la presente investigación realizamos una revisión de los diferentes protocolos utilizados en tomografía con medios de contraste.
El objetivo general de esta investigación fue estandarizar protocolos, Diseñando un Manual de Procedimientos en TC en Exámenes Contrastados, para el servicio de Imagenología del Hospital José Carrasco Arteaga, Cuenca, permitiendo que los procedimientos utilizados en los diferentes estudios sean factibles, precisos y útiles dentro del diagnóstico de patologías.
El método utilizado en el presente estudio fue Descriptivo – Prospectivo.
El universo y la muestra estuvo representado por todo el POE; la muestra es representativa y aleatoria.
Para el levantamiento de datos se utilizó como instrumento la aplicación de una entrevista y encuesta individual previamente validada a los profesionales con preguntas objetivas a ser respondidas textualmente.
Los siguientes resultados de la investigación fueron:
Con respecto al género de los entrevistados, el 55% corresponde al POE del género femenino y el 45% al POE del género masculino.
El grupo de edad con mayor frecuencia fue el de 21 a 30 años que represento el 45% y el de menor frecuencia fue de 51 a 60 años con un porcentaje del 10%.
Sobre el nivel de instrucción, los tecnólogos médicos en radiología solo ocupan un 5%, mientras que los licenciados en imagenología son el 95%.
En el test realizado al POE, el 60% tiene un conocimiento Regular y el 40% tiene un conocimiento bueno sobre el tema, ninguno de los entrevistados llega al nivel muy bueno ni excelente.In the present study we review the different protocols used in CT contrast media.
The overall objective of this research was to standardize protocols, designing a procedures manual in CT examinations Contrasted to the Imaging Service of Hospital José Carrasco Arteaga, Cuenca, allowing the procedures used in the different studies are feasible, accurate and useful within diagnosis of pathologies.
The method used in this study was descriptive - prospective.
The universe and the sample was represented throughout the POE; the sample is representative and random.
Data for the survey applying a previously validated interview and professionals with objective questions to be answered individually verbatim survey was used as an instrument.
The following results of the research were:
With respect to gender of the respondents, 55% corresponds to POE female and 45% male to POE.
The age group most frequently was that of 21-30 years represent 45% and the lowest rate was 51-60 years with a rate of 10%.
On the level of education, medical radiology technologists occupy only 5%, while imaging graduates are 95%.
In the test at the POE, 60% have a regular knowledge and 40% have a good knowledge on the subject, none of the respondents reaches very good or excellent level.Licenciada y Licenciado en ImagenologíaCuenc
Sediment accumulation rates and vertical mixing of deep-sea sediments derived from14C and 210Pb in the southern Gulf of Mexico
Religiones, post-secularidad y democracia en América Latina: reconfiguraciones del discurso y la acción politica
Re-reading Maipina de la Barra: scientific observations in the first travel narrative by a Chilean woman
Políticas públicas
Amputación de extremidades superiores: caracterización epidemiológicaAnálisis comparado de las políticas de promoción de la salud entre Chile y CataluñaAnálisis de los Avisa para la toma de decisiones en políticas de saludAntecedentes de colelitiasis en pacientes que presentaron colecistitis aguda. ¿Se puede prevenir la urgencia?Asociación entre alcoholemia y traumatismos en Copiapó, 2009Automedicación en la población asistente al Cesfam de Puerto NatalesAutotoma vaginal para detección de VPH para la prevención de cáncer cervicouterino, ChileCalidad de atención programa Auge- cáncer cervicouterino: la perspectiva de los profesionalesCaracterización de los casos de traumatismo encéfalo craneano en la comuna de Til-TilConocimiento de conductores universitarios sobre la alcoholemia permitida para conducir y su equivalencia en bebidas alcohólicasDescripción de la consulta dermatológica pediátrica en el Hospital Roberto del Río (2007-2008)Elementos para un abordaje metodológico de la salud intercultural en la Región Metropolitana de SantiagoEstudio descriptivo de consultas Sapu Cesfam Angachilla, visión tras dos años de registro clínico-electrónicoEstudio descriptivo de ingresos a Conin Valdivia, una revisión de 10 años (1998-2008)Estudio descriptivo de pacientes hospitalizados por absceso y celulitis peritonsilar en el hospital de PurranqueEvaluación de la aceptabilidad y consumo de alimentos del Pacam inscritos en el Cesfam Dr. V.M.FEvaluación de la interacción de medicinas alternativas o complementarias (MAC) en dos centros APSExposición a humo de tabaco ambiental. Signos y síntomas respiratorios bajos: estudio de prevalenciaFactores relacionados con la rotación laboral de médicos en consultorios del Gran SantiagoFibrosis quística como patología GES: una mirada críticaHipersensibilidad dentinaria: comparación de diferentes alternativas terapéuticasImpacto del GES en cáncer mamario: seguimiento a 5 años en un hospital del SSMSImplementación de la política nacional de medicamentos: percepción del profesional químico farmacéuticoLa implementación de políticas públicas cambió mortalidad de los pacientes gran quemado en Chile¿La infertilidad debería ser considerada un problema de salud pública en el Perú?Modelo de monitoreo de una política de protección a la infanciaMortalidad materna en el Hospital Dr. Alfredo van Grieken Coro, Estado Falcón, Venezuela 2005-2009Objetivos de desarrollo del milenio. Modelación de la mortalidad infantil Nicaragua - Costa Rica 1978-2008Percepción de riesgo y beneficio respecto del cigarrillo y su relación con el tabaquismo adolescentePolíticas públicas y salud intercultural: la experiencia de la organización indígena Taiñ adkimnPrevalencia de atipias celulares del cuello uterino en mujeres entre 18 y 24 añosProceso de ser histerectomizada: relatos de experiencias de mujeres en un hospital público de SantiagoProceso de ser histerectomizada: relatos de experiencias de mujeres en un hospital público de SantiagoPrograma Auge y cáncer cervicouterino: calidad de atención percibida por las usuarias del programaResolución quirúrgica por patología adenoamigdalina: ¿Es la población mapuche un grupo de riesgo?Resultados de alcoholemias tanatológicas del Servicio Médico Legal de Copiapó 1999-2009Resultados de la evaluación de los objetivos sanitarios de la década 2000-2010Una mirada a los servicios de salud para adolescentes en Puente Alt
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
BackgroundEstimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand this unprecedented event within the context of long-term population health trends. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides new demographic estimates for 204 countries and territories and 811 additional subnational locations from 1950 to 2021, with a particular emphasis on changes in mortality and life expectancy that occurred during the 2020–21 COVID-19 pandemic period.Methods22 223 data sources from vital registration, sample registration, surveys, censuses, and other sources were used to estimate mortality, with a subset of these sources used exclusively to estimate excess mortality due to the COVID-19 pandemic. 2026 data sources were used for population estimation. Additional sources were used to estimate migration; the effects of the HIV epidemic; and demographic discontinuities due to conflicts, famines, natural disasters, and pandemics, which are used as inputs for estimating mortality and population. Spatiotemporal Gaussian process regression (ST-GPR) was used to generate under-5 mortality rates, which synthesised 30 763 location-years of vital registration and sample registration data, 1365 surveys and censuses, and 80 other sources. ST-GPR was also used to estimate adult mortality (between ages 15 and 59 years) based on information from 31 642 location-years of vital registration and sample registration data, 355 surveys and censuses, and 24 other sources. Estimates of child and adult mortality rates were then used to generate life tables with a relational model life table system. For countries with large HIV epidemics, life tables were adjusted using independent estimates of HIV-specific mortality generated via an epidemiological analysis of HIV prevalence surveys, antenatal clinic serosurveillance, and other data sources. Excess mortality due to the COVID-19 pandemic in 2020 and 2021 was determined by subtracting observed all-cause mortality (adjusted for late registration and mortality anomalies) from the mortality expected in the absence of the pandemic. Expected mortality was calculated based on historical trends using an ensemble of models. In location-years where all-cause mortality data were unavailable, we estimated excess mortality rates using a regression model with covariates pertaining to the pandemic. Population size was computed using a Bayesian hierarchical cohort component model. Life expectancy was calculated using age-specific mortality rates and standard demographic methods. Uncertainty intervals (UIs) were calculated for every metric using the 25th and 975th ordered values from a 1000-draw posterior distribution.FindingsGlobal all-cause mortality followed two distinct patterns over the study period: age-standardised mortality rates declined between 1950 and 2019 (a 62·8% [95% UI 60·5–65·1] decline), and increased during the COVID-19 pandemic period (2020–21; 5·1% [0·9–9·6] increase). In contrast with the overall reverse in mortality trends during the pandemic period, child mortality continued to decline, with 4·66 million (3·98–5·50) global deaths in children younger than 5 years in 2021 compared with 5·21 million (4·50–6·01) in 2019. An estimated 131 million (126–137) people died globally from all causes in 2020 and 2021 combined, of which 15·9 million (14·7–17·2) were due to the COVID-19 pandemic (measured by excess mortality, which includes deaths directly due to SARS-CoV-2 infection and those indirectly due to other social, economic, or behavioural changes associated with the pandemic). Excess mortality rates exceeded 150 deaths per 100 000 population during at least one year of the pandemic in 80 countries and territories, whereas 20 nations had a negative excess mortality rate in 2020 or 2021, indicating that all-cause mortality in these countries was lower during the pandemic than expected based on historical trends. Between 1950 and 2021, global life expectancy at birth increased by 22·7 years (20·8–24·8), from 49·0 years (46·7–51·3) to 71·7 years (70·9–72·5). Global life expectancy at birth declined by 1·6 years (1·0–2·2) between 2019 and 2021, reversing historical trends. An increase in life expectancy was only observed in 32 (15·7%) of 204 countries and territories between 2019 and 2021. The global population reached 7·89 billion (7·67–8·13) people in 2021, by which time 56 of 204 countries and territories had peaked and subsequently populations have declined. The largest proportion of population growth between 2020 and 2021 was in sub-Saharan Africa (39·5% [28·4–52·7]) and south Asia (26·3% [9·0–44·7]). From 2000 to 2021, the ratio of the population aged 65 years and older to the population aged younger than 15 years increased in 188 (92·2%) of 204 nations.InterpretationGlobal adult mortality rates markedly increased during the COVID-19 pandemic in 2020 and 2021, reversing past decreasing trends, while child mortality rates continued to decline, albeit more slowly than in earlier years. Although COVID-19 had a substantial impact on many demographic indicators during the first 2 years of the pandemic, overall global health progress over the 72 years evaluated has been profound, with considerable improvements in mortality and life expectancy. Additionally, we observed a deceleration of global population growth since 2017, despite steady or increasing growth in lower-income countries, combined with a continued global shift of population age structures towards older ages. These demographic changes will likely present future challenges to health systems, economies, and societies. The comprehensive demographic estimates reported here will enable researchers, policy makers, health practitioners, and other key stakeholders to better understand and address the profound changes that have occurred in the global health landscape following the first 2 years of the COVID-19 pandemic, and longer-term trends beyond the pandemic